Chemical Biology Ventures

Chemical Biology Ventures (CBV) is a boutique venture capital and company creation firm headquartered in Cambridge, Massachusetts. Founded by prominent chemical biologist Stuart Schreiber and venture capitalist Ben Auspitz, the firm specializes in identifying and launching early-stage biotechnology companies based on transformative academic research. CBV typically operates as a founding investor, providing the initial strategic and financial support to translate complex biological mechanisms into therapeutic platforms. The firm has played a pivotal role in the inception of several high-profile biotechs, including C4 Therapeutics and Kojin Therapeutics. Its investment strategy focuses on high-impact science and novel biological targets, particularly in the areas of oncology and rare diseases.